Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{193182,
        author = {DR. HARITHA SRI PONNADA and DR. G. SRINIVAS},
        title = {UNDERSTANDING RHABDOMYOLYSIS – THE IMPACT OF STATIN THERAPY},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {9},
        pages = {4254-4257},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=193182},
        abstract = {Statins are widely prescribed lipid-lowering agents with an excellent safety profile, though rare cases of rhabdomyolysis can occur. We report a 65-year-old male who developed severe myalgia, myoglobinuria, elevated creatine kinase (8561 U/L), and acute kidney injury following high-dose atorvastatin after primary PCI. Prompt statin withdrawal and aggressive intravenous hydration led to clinical improvement. This case highlights the need for early recognition of statin-induced muscle toxicity.},
        keywords = {Acute kidney injury; Acute coronary syndrome; Atorvastatin; Creatine kinase; Drug-induced myopathy; Myalgia; Myoglobinuria; Percutaneous coronary intervention; Rhabdomyolysis; Statins.},
        month = {February},
        }